Dialysis Market - By Type (Hemodialysis, Peritoneal Dialysis), By Product & Service (Equipment, Consumables, Services), By End-use (In-center Dialysis, Home Dialysis), & Global Forecast, 2023-2032
Published on: 2024-08-01 | No of Pages : 240 | Industry : Healthcare
Publisher : MIR | Format : PDF&Excel
Dialysis Market - By Type (Hemodialysis, Peritoneal Dialysis), By Product & Service (Equipment, Consumables, Services), By End-use (In-center Dialysis, Home Dialysis), & Global Forecast, 2023-2032
Dialysis Market Size
Dialysis Market size was worth over USD 95 billion in 2022 and is projected to witness substantial growth at a robust pace of more than 5% CAGR through 2032 driven by the expanding patient pool of end-stage renal diseases (ESRD).
According to the National Center for Biotechnology Information, chronic kidney disease is a degenerative disorder that affects more than 10% of the global population, or over 800 million people. The rising incidence of these illnesses is mainly driven by the rising prevalence of obesity, hypertension, diabetes mellitus, and the growing geriatric population, which is projected to propel the market progress. Furthermore, the surge in the frequency and mortality associated with chronic renal disease is one of the important characteristics that is anticipated to be beneficial to the market.
| Report Attribute | Details |
|---|---|
| Base Year | 2022 |
| Dialysis Market Size in 2022 | USD 95. Billion |
| Forecast Period | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR | 5% |
| 2032 Value Projection | USD 153 Billion |
| Historical Data for | 2018 to 2022 |
| No. of Pages | 220 |
| Tables, Charts & Figures | 495 |
| Segments covered | Type, Product & Service, End-use, and Region |
| Growth Drivers | |
| Pitfalls & Challenges |
Complicated treatment procedures to slow down industry landscape
Significant documented consequences of undergoing dialysis include dysrhythmia precipitation, arterial puncture, venous thrombosis, pneumothorax, catheter malposition, and catheter-associated infection. Moreover, some central venous catheters (CVCs) are associated with high morbidity, mortality, and cost. Acute mechanical problems related to hemodialysis catheter insertion, such as vascular damage or hematoma, are prevalent, accounting for around 5% of catheter insertions. In the foreseeable future, such problems and morbidities connected with the use of dialysis products may hamper the adoption of dialysis therapies. Nonetheless, continued R&D activities to enhance dialysis products and methods are likely to assist manufacturers in overcoming this restraint.
Dialysis Market Analysis
As per type, the dialysis market share from the hemodialysis segment is estimated to reach over USD 135 billion by 2032 attributed to the rising number of end-stage renal disease patients worldwide. In 2021, around 786,000 people suffer from ESRD in the U.S., as per the National Institute of Diabetes and Digestive and Kidney Diseases. Moreover, hospitals are focusing on improving the availability of hemodialysis to complement their current renal services, which is expected to promote segment expansion. For instance, in July 2022, Pantai Hospital Klang opened a new Haemodialysis Centre to serve chronic kidney disease patients in Klang, Malaysia, and the surrounding area, allowing them to receive treatment closer to home.
Services segment held over 78% share of the dialysis market in 2022 and is likely to grow exponentially through 2032 with the surging occurrences of renal illnesses, which is increasing the number of patients needing dialysis and transplants. Industry participants are seizing opportunities to offer new dialysis delivery services and other technologies to treat the most advanced stages of kidney function failures and disease. For instance, in March 2022, SEHA Kidney Care, a subsidiary of Abu Dhabi Health Services Company (SEHA) which is UAE's largest healthcare network, launched an overnight dialysis service to meet the community's diverse needs. Such initiatives are anticipated to stimulate segment growth.
In terms of end-use, the dialysis market by the home dialysis segment generated over USD 28 billion in 2022, owing to the COVID-19 pandemic, which has increased the preference for home dialysis. Home dialysis procedure provides greater patient autonomy, financial benefits, and treatment-related flexibility, and is associated with improved quality of life and survival. Furthermore, to alleviate the strain on dialysis facilities and provide a more sustainable dialysis care delivery system, governments, and healthcare institutions in densely populated underdeveloped regions are promoting home-based dialysis, which is likely to augment segment revenues.
North America dialysis market valuation is anticipated to exceed USD 65.5 billion by 2032 owing to the increasing prevalence of chronic kidney disease & end-stage renal disease. As per the National Institute of Diabetes and Digestive and Kidney Diseases, more than one in every seven adults in the U.S. suffers from chronic kidney disease. Furthermore, the increasing availability of reimbursement schemes and favorable government initiatives are projected to favor the U.S. dialysis market, thereby bolstering regional business expansion. To cite an instance, the Centers for Medicare & Medicaid Services (CMS) reimburses dialysis expenses through a prospective payment system (PPS), which allows for the payment of a predetermined amount to dialysis service providers.
Dialysis Market Share
Some of the major companies operating in the dialysis market are
- Medtronic Plc
- AngioDynamics, Inc.
- Baxter International Inc.
- JMS Co Ltd
- Becton
- Dickinson and Company
- Teleflex Incorporated
- Nipro Medical Corporation
- DaVita Inc.
- Dialife SA
- Toray Industries Inc.
To increase their market share, these businesses frequently engage in partnerships, acquisitions, and service portfolio expansions. For instance, in March 2022, B. Braun, a German medical & pharmaceutical device company, acquired Intermedt Medizin & Technik GmbH, a specialist in the preparation of dialysis concentrates. This enabled B. Braun to enhance its R&D capabilities for the advancement of hemodialysis in a simple, flexible, and environment-friendly way, fortifying its foothold in the sector.
Impact of COVID-19 Pandemic
The COVID-19 pandemic affected virtually all industries and led to significant financial hardship for healthcare services by increasing healthcare expenses. The implementation of social distancing norms and the revision of standard operating protocols hampered the daily operations of several healthcare services, such as dialysis processes. Many healthcare facilities suspended or rescheduled routine care and only provided emergency care. However, urgent dialysis procedures were carried out in medical facilities, despite the coronavirus crisis. As the number of COVID-19 cases decreased in several countries, healthcare facilities resumed providing healthcare services, gradually stabilizing the procedural volume to pre-pandemic levels, which is positively influencing the market scenario.
The dialysis market research report includes in-depth coverage of the industry with estimates & forecasts in terms of revenue in USD from 2018 to 2032, for the following segments
Click here to Buy Section of this Report
By Type
- Hemodialysis
- Peritoneal Dialysis
By Product and Services
- Equipment
- Dialysis Machines
- Water Treatment Systems
- Others
- Consumables
- Dialyzers
- Catheters
- Access Products
- Concentrates
- Others
- Services
- Acute dialysis
- Chronic dialysis
By End-use
- In-center Dialysis
- Home Dialysis
The above information is provided for the following regions and countries
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Poland
- Sweden
- The Netherlands
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Indonesia
- Philippines
- Malaysia
- Latin America
- Brazil
- Mexico
- Argentina
- Chile
- Colombia
- Peru
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Egypt